About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Los Angeles | 4,650 Studies Near You

Clinical TrialsLos Angeles

Clinical Trials in Los Angeles

Discover 4,650 clinical trials near Los Angeles, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1981-2000 of 4,650 trials

CompletedEducational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart FailureHeart failure (HF) affects 5 million people in the United States.NCT00378950·Los Angeles, California and 3 others CompletedA Study of INCB018424 Phosphate Cream in Subjects With VitiligoThe purpose of this study will be to examine the efficacy, safety, and tolerability of ruxolitinib cream in subjects with vitiligo.NCT03099304·Birmingham, Alabama and 25 others

Find Trials by Condition in Los Angeles

Breast Cancerin Los Angeles Lung Cancerin Los Angeles Prostate Cancerin Los Angeles Colorectal Cancerin Los Angeles Melanomain Los Angeles Leukemiain Los Angeles Lymphomain Los Angeles Pancreatic Cancerin Los Angeles Ovarian Cancerin Los Angeles Brain Cancerin Los Angeles

Data from ClinicalTrials.govTerms

CompletedBortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)This is a Phase I/II study of a drug called bortezomib given in combination with chemotherapy drugs used to treat acute lymphoblastic leukemia (ALL) that has come back (recurred).NCT00440726·Duarte, California and 23 others

CompletedA Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsThe purpose of this study is to evaluate the safety and tolerance of 2 anti-HIV drugs, d4T and 3TC, given in combination to HIV-positive pregnant women and their infants.NCT00000878·Los Angeles, California and 19 others

CompletedSafety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive ChildrenThe purpose of this study is to see if PEG-Intron is safe and tolerated when given to children, to see how much gets into the blood and how long it stays in the blood, and to see…NCT00006325·Long Beach, California and 14 others

CompletedMedications for Chronic HIV: Education and CollaborationThis study will examine whether a computerized, self-administered assessment of patient medication adherence and health behaviors, plus support for adherence, improves the ability…NCT01038076·Los Angeles, California and 2 others

CompletedEfficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural MesotheliomaThis study will evaluate intrapleural administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in combination with Celecoxib and Gemcitabine in patients with…NCT03710876·Los Angeles, California and 28 others

CompletedFludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)The purpose of the current study is to continue to optimize conditioning regimens in high-risk patients with severe aplastic anemia transplanted with marrow from HLA-compatible…NCT00326417·Phoenix, Arizona and 21 others

CompletedEfficiency and Safety of Holmium Laser With Moses Technology Versus SuperPulsed Laser System With Thulium Fiber Laser on Renal StonesThis is a prospective randomized controlled trial designed to assess the efficacy and safety of Lumenis® Pulse™ P120H holmium laser system with the Moses technology (holmium laser…NCT06070714·Los Angeles, California and 3 others

TerminatedA Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)This study will compare the efficacy and safety of unesbulin plus dacarbazine versus placebo plus dacarbazine in participants with unresectable or metastatic, relapsed or…NCT05269355·Duarte, California and 53 others

CompletedOpen-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum DisordersThe study objective is to explore the safety and tolerability of STX209 in subjects with Autism Spectrum Disorders and to obtain preliminary data on several measures of efficacy…NCT00846547·Phoenix, Arizona and 7 others

Active not recruitingCase-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular CarcinomaClinical guidelines (AASLD) recommend the use of abdominal ultrasound (US) for surveillance testing for the early detection of Hepatocellular Carcinoma (HCC).NCT03878550·Los Angeles, California and 19 others

UnknownPaclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal TumorsThis randomized phase II trial studies paclitaxel and carboplatin to see how well they work compared with bleomycin sulfate, etoposide phosphate, and cisplatin in treating…NCT01042522·Anchorage, Alaska and 218 others

Active not recruitingA Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)* To evaluate the safety and tolerability of escalating doses of ERAS-801 in study participants with recurrent glioblastoma multiforme (GBM).NCT05222802·Los Angeles, California and 7 others

CompletedPrecision Diagnosis of Acute Infectious Diseases; Neuroinflammatory CohortThis study aims to use a clinically validated metagenomic next-generation sequencing (mNGS) assay to provide a demonstration of precision medicine for diagnosis of acute…NCT02910037·Davis, California and 6 others

Active not recruitingTesting the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial CancerThis phase III trial compares whether the addition of pembrolizumab to radiation therapy is more effective than radiation therapy alone in reducing the risk of cancer coming back…NCT04214067·Birmingham, Alabama and 279 others

CompletedPatient Portal Flu Vaccine Reminders (RCT 6)This trial is taking place in Los Angeles, CA at 21 clinics within the UCLA Health System. The study design is a 3 arm randomized trial.NCT06062264·Los Angeles, California

Active not recruitingSporadic Inclusion Body Myositis Natural History StudyThis is a prospective natural history study on patients with clinically defined sIBM. Participants will be assessed every 6 months over two years (five visits total).NCT05046821·Los Angeles, California and 12 others

Active not recruitingTesting the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic LeukemiaThis phase III trial compares adding a new anti-cancer drug (venetoclax) to the usual treatment (ibrutinib plus obinutuzumab) in older patients with chronic lymphocytic leukemia…NCT03737981·Birmingham, Alabama and 856 others

Not yet recruitingAn International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac FunctionThis project aims to evaluate a new cardiac MRI technique called the Free-Running Framework (FRF), which could simplify and accelerate the process of acquiring cardiac images.NCT07613398·Los Angeles, California and 19 others

PreviousPage 100 of 233Next

Diabetes

in Los Angeles

Heart Diseasein Los Angeles